Letter comments re: Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A NCDB analysis.
- Resource Type
- Editorial & Opinion
- Authors
- Jonas E; University of Cape Town Faculty of Health Sciences, Cape Town, South Africa. Electronic address: eduard.jonas@uct.ac.za.; Lindemann J; Washington University School of Medicine, Washington University in St Louis, USA.; Bernon M; University of Cape Town Faculty of Health Sciences, Cape Town, South Africa.; Krige J; University of Cape Town Faculty of Health Sciences, Cape Town, South Africa.
- Source
- Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: PubMed not MEDLINE; MEDLINE
- Subject
- Language
- English
Competing Interests: Conflict of interest statement All authors declare that they do not have any actual or potential conflict of interest, including any financial, personal or other relationships with other people or organisations within that could inappropriately influence (bias) this work.